110 related articles for article (PubMed ID: 22331930)
21. Infiltrating lobular carcinoma of the breast: systemic treatment.
Farese SA; Aebi S
Breast Dis; 2008-2009; 30():45-52. PubMed ID: 19850995
[TBL] [Abstract][Full Text] [Related]
22. Phase 2, multicenter, single-arm study of eribulin mesylate with trastuzumab as first-line therapy for locally recurrent or metastatic HER2-positive breast cancer.
Wilks S; Puhalla S; O'Shaughnessy J; Schwartzberg L; Berrak E; Song J; Cox D; Vahdat L
Clin Breast Cancer; 2014 Dec; 14(6):405-12. PubMed ID: 25024001
[TBL] [Abstract][Full Text] [Related]
23. Response to neoadjuvant chemotherapy in patients with advanced breast cancer: a local hospital experience.
Khokher S; Mahmood S; Khan SA
Asian Pac J Cancer Prev; 2010; 11(2):303-8. PubMed ID: 20843105
[TBL] [Abstract][Full Text] [Related]
24. Preoperative taxane-based chemotherapy in a standardized protocol for locally advanced breast cancer.
Chan A; Willsher PC; Hastrich DJ; Anderson J; Barham T; Latham B; Redfern A; VAN DER Schaaf A; Thomson J; Joseph D; Ingram D
Asia Pac J Clin Oncol; 2012 Mar; 8(1):62-70. PubMed ID: 22369445
[TBL] [Abstract][Full Text] [Related]
25. [A case of combined noninvasive ductal and lobular carcinoma].
Nagashima S; Sakurai K; Suzuki S; Hara Y; Waga E; Iizuka M; Fuchinoue T; Hirano T; Enomoto K; Tani M; Masuda S; Amano S; Koshinaga T
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2033-5. PubMed ID: 23267967
[TBL] [Abstract][Full Text] [Related]
26. FOXA1 Expression Significantly Predict Response to Chemotherapy in Estrogen Receptor-Positive Breast Cancer Patients.
Xu C; Wei Q; Guo J; Zhou JC; Mei J; Jiang ZN; Shen JG; Wang LB
Ann Surg Oncol; 2015; 22(6):2034-9. PubMed ID: 25707489
[TBL] [Abstract][Full Text] [Related]
27. Preoperative chemotherapy decreases the need for re-excision of breast cancers between 2 and 4 cm diameter.
Christy CJ; Thorsteinsson D; Grube BJ; Black D; Abu-Khalaf M; Chung GG; DiGiovanna MP; Miller K; Higgins SA; Weidhaas J; Harris L; Tavassoli FA; Lannin DR
Ann Surg Oncol; 2009 Mar; 16(3):697-702. PubMed ID: 19132447
[TBL] [Abstract][Full Text] [Related]
28. Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients.
Duman BB; Afşar ÇU; Günaldi M; Sahin B; Kara IO; Erkisi M; Erçolak V
Asian Pac J Cancer Prev; 2012; 13(8):4119-23. PubMed ID: 23098527
[TBL] [Abstract][Full Text] [Related]
29. Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy.
Parton M; Krajewski S; Smith I; Krajewska M; Archer C; Naito M; Ahern R; Reed J; Dowsett M
Clin Cancer Res; 2002 Jul; 8(7):2100-8. PubMed ID: 12114409
[TBL] [Abstract][Full Text] [Related]
30. Gallbladder metastases of breast cancer: from clinical-pathological patterns to diagnostic and therapeutic strategy.
Di Vita M; Zanghì A; Lanzafame S; Cavallaro A; Piccolo G; Berretta M; Grosso G; Cappellani A
Clin Ter; 2011; 162(5):451-6. PubMed ID: 22041804
[TBL] [Abstract][Full Text] [Related]
31. [Hormone therapy as primary therapy of operable breast carcinoma in elderly patients].
Foudraine NA; Verhoef CG; Burghouts TM
Ned Tijdschr Geneeskd; 1993 Nov; 137(46):2345-7. PubMed ID: 8264814
[No Abstract] [Full Text] [Related]
32. Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome.
Karanlik H; Ozgur I; Cabioglu N; Sen F; Erturk K; Kilic B; Onder S; Deniz M; Yavuz E; Aydiner A
Eur J Surg Oncol; 2015 Sep; 41(9):1226-33. PubMed ID: 26141784
[TBL] [Abstract][Full Text] [Related]
33. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy.
Gasparini G; Barbareschi M; Boracchi P; Verderio P; Caffo O; Meli S; Dalla Palma P; Marubini E; Bevilacqua P
Cancer J Sci Am; 1995; 1(2):131-41. PubMed ID: 9166466
[TBL] [Abstract][Full Text] [Related]
34. Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Nikolényi A; Sükösd F; Kaizer L; Csörgo E; Vörös A; Uhercsák G; Ormándi K; Lázár G; Thurzó L; Brodowicz T; Kahán Z
Oncology; 2011; 80(3-4):269-77. PubMed ID: 21734419
[TBL] [Abstract][Full Text] [Related]
35. Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy.
Helvie MA; Joynt LK; Cody RL; Pierce LJ; Adler DD; Merajver SD
Radiology; 1996 Feb; 198(2):327-32. PubMed ID: 8596826
[TBL] [Abstract][Full Text] [Related]
36. Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype.
Alramadhan M; Ryu JM; Rayzah M; Nam SJ; Kim SW; Yu J; Lee SK; Bae SY; Park S; Paik HJ; Lee JE
Breast; 2016 Dec; 30():111-117. PubMed ID: 27697675
[TBL] [Abstract][Full Text] [Related]
37. Trabectedin as a single-agent treatment of advanced breast cancer after anthracycline and taxane treatment: a multicenter, randomized, phase II study comparing 2 administration regimens.
Goldstein LJ; Gurtler J; Del Prete SA; Tjulandin S; Semiglazov VF; Bayever E; Michiels B
Clin Breast Cancer; 2014 Dec; 14(6):396-404. PubMed ID: 25239225
[TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node biopsy is precise after primary systemic therapy in stage II-III breast cancer patients.
Reitsamer R; Menzel C; Glueck S; Rettenbacher L; Weismann C; Hutarew G
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():286-90. PubMed ID: 20853048
[TBL] [Abstract][Full Text] [Related]
39. Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor-negative breast cancer patients.
Ploner F; Jakesz R; Hausmaninger H; Kolb R; Stierer M; Fridrik M; Steindorfer P; Gnant M; Haider K; Mlineritsch B; Tschurtschenthaler G; Steger G; Seifert M; Kubista E; Samonigg H;
Onkologie; 2003 Apr; 26(2):115-9. PubMed ID: 12771518
[TBL] [Abstract][Full Text] [Related]
40. The outcome effect of double-hormonal therapy in premenopausal breast cancer patients with high nodal-status: Result of a prospective randomized trial.
Uslu A; Zengel B; Akpinar G; Postaci H; Yetis H; Corumlu B; Kebapci E; Aykas A
Indian J Cancer; 2014; 51(4):582-6. PubMed ID: 26842203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
